New drug that disrupts two cellular targets would make it much harder for bacteria to evolve resistance.
The neurological disease is estimated to affect more than ten million people globally
I agree with Issa and colleagues1 that healthcare systems cannot operate effectively without sustainability as a central consideration […]
Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment […]
A new compound shows promise in overcoming chemotherapy resistance in triple-negative breast cancer — and could potentially be […]
A former consultant colorectal surgeon has been suspended from the UK medical register for six months for carrying […]
The Scottish government is set to publish new guidance for doctors to reduce the use of treatments that […]
Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
